Ketamine inhibits serotonin uptake in vivo

Neuropharmacology

Volumn 21, Issue 2, 1982, Pages 113-118

  Martin, L L ^a   Bouchal, Rena L ^a   Smith, D J ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHETAMINE; FLUOXETINE; KETAMINE; NIALAMIDE; RADIOISOTOPE; RESERPINE; SEROTONIN;

ANIMAL EXPERIMENT; BRAIN; CENTRAL NERVOUS SYSTEM; DOSE RESPONSE; DRUG INTERACTION; DRUG RESPONSE; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN H 3; SPIPERONE H 3;

ANIMAL; BRAIN; FENCLONINE; FLUOXETINE; KETAMINE; MALE; NIALAMIDE; RATS; RATS, INBRED STRAINS; RECEPTORS, SEROTONIN; RESERPINE; SEROTONIN; SPIPERONE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0020031255     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(82)90149-6     Document Type: Article

References (33)

1. Action of psychotogenic drugs on single midbrain raphe neurons
2. Medical Summary
3. Conjoint native and orthophthaldialdehyde condensate assays for the fluorimetric determination of 5-hydroxyindoles in brain
4. 3H]-gamma-aminobutyric acid uptake
5. Inhibition of the serotonergic uptake system by MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine)
6. Distribution in the brain and metabolism of ketamine in the rat after intravenous administration
7. A relationship between clinical efficacy and various biochemical parameters of monoamine oxidase inhibitors (MAOI's)
8. Reversible and irreversible phases of serotonin depletion by 4-chloro-amphetamine
9. Inhibition of serotonin reuptake
10. 3H]-dopa in various regions of the brain
11. The effects of quipazine on 5-HT metabolism in the rat brain
12. Stereo-typed hyperactivity in rats treated with tranylcypromine and specific inhibitors of 5-HT reuptake
13. Method for the determination of norepinephrine, dopamine and serotonin in the same brain region
14. A double-blind controlled study of a serotonin uptake inhibitor (zime-lidine) versus placebo in chronic pain patients
15. Ketamine anesthesia
16. Effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake, on morphine analgesia and the development of tolerance
17. Ketamine inhibits serotonin kynthesis and metabolism in vivo
18. General anesthetic and other pharmacological properties of 2-chlorophenyl-2-methylamino-cyclohexanone HCl (CI-581)
19. Serotonin-containing neurons: their possible role in pain and analgesia
20. Analgesic effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake
21. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihy-droxytryptamine administration in the rat
22. Ketamine analgesia: mediation by biogenic amine and endogenous opiateprocesses
23. 3H]-spiroperidol
24. Ketamine: “dissociative agent” or hallucinogen?
25. Pharmacological effects in man of a specific serotonin-reuptake inhibitor
26. Serotonergic mechanisms of narcotic action
27. Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms
28. Specificity of a rat behavioral model for serotonin receptor activation
29. The interaction of ketamine with the opiate receptor
30. On the role of 5-hydroxytryptamine in drug-induced antinociception
31. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD
32. An anesthetic agent: 2-orthochlorophenyll,2-methylamino cyclohexa-none HCl (CI-581)
33. Spinal serotonin terminal system mediates antinociception